Vasanti S Malik1, Yanping Li1, An Pan2, Lawrence De Koning3, Eva Schernhammer4,5, Walter C Willett1,4,5, Frank B Hu1,4,5. 1. Departments of Nutrition (V.S.M., Y.L., W.C.W., F.B.H.), Harvard T.H. School of Public Health, Boston, MA. 2. Department of Epidemiology and Biostatistics, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (A.P.). 3. Departments of Pathology and Laboratory Medicine, Community Health Sciences and Pediatrics, University of Calgary, Alberta, Canada (L.D.K.). 4. Epidemiology (E.S., W.C.W., F.B.H.), Harvard T.H. School of Public Health, Boston, MA. 5. Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (E.S., W.C.W., F.B.H.).
Abstract
BACKGROUND: Whether consumption of sugar-sweetened beverages (SSBs) or artificially sweetened beverages (ASBs) is associated with risk of mortality is of public health interest. METHODS: We examined associations between consumption of SSBs and ASBs with risk of total and cause-specific mortality among 37 716 men from the Health Professional's Follow-up study (from 1986 to 2014) and 80 647 women from the Nurses' Health study (from 1980 to 2014) who were free from chronic diseases at baseline. Cox proportional hazards regression was used to estimate hazard ratios and 95% confidence intervals. RESULTS: We documented 36 436 deaths (7896 cardiovascular disease [CVD] and 12 380 cancer deaths) during 3 415 564 person-years of follow-up. After adjusting for major diet and lifestyle factors, consumption of SSBs was associated with a higher risk of total mortality; pooled hazard ratios (95% confidence intervals) across categories (<1/mo, 1-4/mo, 2-6/week, 1-<2/d, and ≥2/d) were 1.00 (reference), 1.01 (0.98, 1.04), 1.06 (1.03, 1.09), 1.14 (1.09, 1.19), and 1.21 (1.13, 1.28; P trend <0.0001). The association was observed for CVD mortality (hazard ratio comparing extreme categories was 1.31 [95% confidence interval, 1.15, 1.50], P trend <0.0001) and cancer mortality (1.16 [1.04, 1.29], P trend =0.0004). ASBs were associated with total and CVD mortality in the highest intake category only; pooled hazard ratios (95% confidence interval) across categories were 1.00 (reference), 0.96 (0.93, 0.99), 0.97 (0.95, 1.00), 0.98 (0.94, 1.03), and 1.04 (1.02, 1.12; P trend = 0.01) for total mortality and 1.00 (reference), 0.93 (0.87, 1.00), 0.95 (0.89, 1.00), 1.02 (0.94, 1.12), and 1.13 (1.02, 1.25; P trend = 0.02) for CVD mortality. In cohort-specific analysis, ASBs were associated with mortality in NHS (Nurses' Health Study) but not in HPFS (Health Professionals Follow-up Study) ( P interaction, 0.01). ASBs were not associated with cancer mortality in either cohort. CONCLUSIONS: Consumption of SSBs was positively associated with mortality primarily through CVD mortality and showed a graded association with dose. The positive association between high intake levels of ASBs and total and CVD mortality observed among women requires further confirmation.
BACKGROUND: Whether consumption of sugar-sweetened beverages (SSBs) or artificially sweetened beverages (ASBs) is associated with risk of mortality is of public health interest. METHODS: We examined associations between consumption of SSBs and ASBs with risk of total and cause-specific mortality among 37 716 men from the Health Professional's Follow-up study (from 1986 to 2014) and 80 647 women from the Nurses' Health study (from 1980 to 2014) who were free from chronic diseases at baseline. Cox proportional hazards regression was used to estimate hazard ratios and 95% confidence intervals. RESULTS: We documented 36 436 deaths (7896 cardiovascular disease [CVD] and 12 380 cancer deaths) during 3 415 564 person-years of follow-up. After adjusting for major diet and lifestyle factors, consumption of SSBs was associated with a higher risk of total mortality; pooled hazard ratios (95% confidence intervals) across categories (<1/mo, 1-4/mo, 2-6/week, 1-<2/d, and ≥2/d) were 1.00 (reference), 1.01 (0.98, 1.04), 1.06 (1.03, 1.09), 1.14 (1.09, 1.19), and 1.21 (1.13, 1.28; P trend <0.0001). The association was observed for CVDmortality (hazard ratio comparing extreme categories was 1.31 [95% confidence interval, 1.15, 1.50], P trend <0.0001) and cancer mortality (1.16 [1.04, 1.29], P trend =0.0004). ASBs were associated with total and CVDmortality in the highest intake category only; pooled hazard ratios (95% confidence interval) across categories were 1.00 (reference), 0.96 (0.93, 0.99), 0.97 (0.95, 1.00), 0.98 (0.94, 1.03), and 1.04 (1.02, 1.12; P trend = 0.01) for total mortality and 1.00 (reference), 0.93 (0.87, 1.00), 0.95 (0.89, 1.00), 1.02 (0.94, 1.12), and 1.13 (1.02, 1.25; P trend = 0.02) for CVDmortality. In cohort-specific analysis, ASBs were associated with mortality in NHS (Nurses' Health Study) but not in HPFS (Health Professionals Follow-up Study) ( P interaction, 0.01). ASBs were not associated with cancer mortality in either cohort. CONCLUSIONS: Consumption of SSBs was positively associated with mortality primarily through CVDmortality and showed a graded association with dose. The positive association between high intake levels of ASBs and total and CVDmortality observed among women requires further confirmation.
Authors: F B Hu; E Rimm; S A Smith-Warner; D Feskanich; M J Stampfer; A Ascherio; L Sampson; W C Willett Journal: Am J Clin Nutr Date: 1999-02 Impact factor: 7.045
Authors: Matthias B Schulze; JoAnn E Manson; David S Ludwig; Graham A Colditz; Meir J Stampfer; Walter C Willett; Frank B Hu Journal: JAMA Date: 2004-08-25 Impact factor: 56.272
Authors: Deirdre K Tobias; An Pan; Chandra L Jackson; Eilis J O'Reilly; Eric L Ding; Walter C Willett; JoAnn E Manson; Frank B Hu Journal: N Engl J Med Date: 2014-01-16 Impact factor: 91.245
Authors: Vasanti S Malik; Barry M Popkin; George A Bray; Jean-Pierre Després; Walter C Willett; Frank B Hu Journal: Diabetes Care Date: 2010-08-06 Impact factor: 19.112
Authors: Eva S Schernhammer; Kimberly A Bertrand; Brenda M Birmann; Laura Sampson; Walter C Willett; Diane Feskanich Journal: Am J Clin Nutr Date: 2012-10-24 Impact factor: 8.472
Authors: Hee Young Yun; Lesley F Tinker; Marian L Neuhouser; Dale A Schoeller; Yasmin Mossavar-Rahmani; Linda G Snetselaar; Linda V Van Horn; Charles B Eaton; Ross L Prentice; Johanna W Lampe; Diane M O'Brien Journal: J Nutr Date: 2020-10-12 Impact factor: 4.798
Authors: Lorena Sonia Pacheco; James Vincent Lacey; Maria Elena Martinez; Hector Lemus; Dorothy Dee Sears; Maria Rosario G Araneta; Cheryl Ann Marie Anderson Journal: J Acad Nutr Diet Date: 2021-08-11 Impact factor: 4.910
Authors: Kana Wu; Edward Giovannucci; Yin Cao; Jinhee Hur; Ebunoluwa Otegbeye; Hee-Kyung Joh; Katharina Nimptsch; Kimmie Ng; Shuji Ogino; Jeffrey A Meyerhardt; Andrew T Chan; Walter C Willett Journal: Gut Date: 2021-05-06 Impact factor: 23.059